Cryoablation: A Minimally Invasive Alternative for Early-Stage Breast Cancer: 6-Year Outcomes of the FROST Clinical Trial
The FROST trial adds to the growing body of literature supporting the efficacy and safety of cryoablation and supports ongoing research on cryoablation as a strategy for de-escalating breast cancer therapy.
Authors
- K. Kozlowski
- L. Kruper
- M. Plaza
- S. Manoian
- S. Patterson
- D. R. Holmes
- P. Littrup
- L. Bailey
- J. Tamayo
- S. Abe
- V. Jones
- R. C. Ward
- N. Z. Carp
- R. Layeequr Rahman
Institutions
- Texas Tech University (US)
- University of California, San Francisco (US)
- Brown University (US)
- Naples Community Hospital Healthcare System (US)
- Lankenau Medical Center (US)
- University of Rochester Medical Center (US)
- Moffitt Cancer Center (US)
- Virginia Oncology Associates (US)
- Analytical Mechanics Associates (United States) (US)
- Beverly Hills Cancer Center (US)
- Southwest Regional Wound Care Center (US)
- Arnot Ogden Medical Center (US)
- City of Hope (US)
- Naples Anesthesia & Physician Associates (US)
- Adventist Health Glendale (US)
- Epic Care (US)
- Crittenton Hospital Medical Center (US)
- Hampton Roads Sanitation District (US)
- Alta Bates Summit Medical Center (US)
- Texas Tech University Health Sciences Center (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1245/s10434-025-18991-2
- Primary Topic
- Ultrasound and Hyperthermia Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00